Where others have failed will Atl1102 succeed ?, page-62

First 62 Last

Share
Profile

Follow
Uboy

4,683 Posts.

1086

22/05/21

15:02

Post #: 53350040
Share

Originally posted by itsagas ↑

Thanks : If one listened to Diamond on his last Webinar one would deduct that he was telling shareholders to HOLD.. Not only did he emphasise that end points are the same as the last DMD trial, the comparison of other biotechs ( MC and end points met and exceeded), etc

But if one paid close attention one would have heard him say that there are many small indications and a couple of LARGER ones....

What people don’t understand is that they see no results
until I’ll 2022 and the sp would remain stagnant .I say it again ..these New Indications will be partnered with Big Pharma...Liscence fees and MILESTONE payments mean $$$ NO MORE DILUTION..

It really annoys me when people say Akki contributes.. joke.... Sam, George 1972 and a few others would be insulted because I enjoy reading their posts...and they have confirmed my thoughts...
Yes I’m guilty of predicting $1 by Christmas for the past 4 years... but shit happens with delays etc... However
in the next 10 days we will be delighted because the race is run.... $5 is chicken feed...$$$
A special Thank You to Sam: we have had many disagreements however we always believed in the Anp story....

Expand

Who here is tipping one big trial to include both EMA and FDA arms?

Data to be used by both for early approval?

Exciting month ahead.

ANP Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Shekel Brainweigh and Calmer Co lead innovations in the retail space

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

There are more pages in this discussion • 1,035 more messages in this thread...

First 62 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
8.1¢	8.1¢	7.9¢	$33.53K	416.4K

Buyers (Bids)

No.	Vol.	Price($)
2	92000	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	65186	3

View Market Depth

No.	Vol.	Price($)
2	92000	0.079
2	212658	0.078
1	200000	0.077
2	66500	0.076
4	206988	0.075

Price($)	Vol.	No.
0.080	65186	3
0.082	97561	1
0.083	214000	1
0.084	161142	2
0.085	141000	2

Last trade - 16.10pm 15/07/2024 (20 minute delay)

PER (ASX) Chart

Where others have failed will Atl1102 succeed ?, page-62

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Where others have failed will Atl1102 succeed ?, page-62

Top Stories

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News